Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-07-02 18:27:58 ET · period of report 2026-06-30 · accession 0001805688-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 18:27 | 2026-06-30 | JAZZ | Pearce Samantha | EVP, Chief Commercial Off | F - Tax | $237.72 | -2,527 | 47.9K | -5% | -$600.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-30 | F | D | 2,527 | $237.72 | 47,911 | D | — | — | (F1) Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. (F2) The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026. |